Vaccinations

The vaccine is designed to prevent hepatitis A in children up to 15 years of age. It is particularly recommended for pre-schoolers, schoolchildren and young adults who have not had hepatitis A, as well as children and young adults travelling to countries with poor hygiene and sanitary conditions, such as Bulgaria, Tunisia, Egypt, Russia, countries in the Mediterranean basin, Africa and Eastern Europe. Two doses of the vaccine provide immunity for life.

The vaccine is designed to prevent hepatitis A in adults and young adults over 16 years of age. It is particularly recommended for people planning to travel to Africa, Asia and most Eastern European countries; people working in food production and distribution, catering staff, as well as for people in groups at risk. The vaccine provides long-lasting immunity.

The goal of the vaccine is to prevent lower respiratory tract diseases caused by RSV—a virus that can be especially dangerous for older adults and those with weakened immune systems.

The vaccine contains a purified, toxoid form of the tetanus toxin, which stimulates the immune system to produce antibodies. This gives the body resistance to the effects of the toxin.

ENGERIX is a vaccine designed to protect adults and individuals aged 16 and older against hepatitis B. It is especially recommended for people planning to travel to Africa, Southeast Asia, or the Eastern Mediterranean; for patients preparing to undergo surgical, dental, or cosmetic procedures; and for women planning to become pregnant. When the full vaccination schedule is completed, it provides lifelong immunity.

The vaccine is designed to prevent cholera in children over 2 years of age, adults and is particularly recommended for people travelling to areas with an increased risk of infection, such as Africa, Asia, and Central America.

The vaccine is designed to prevent Japanese encephalitis in adults, adolescents, children and infants from two months of age (and older) who travel to areas where there is a risk of Japanese encephal infection.

The purpose of the vaccine is to protect children aged 9 months and older and adults who plan to travel to regions at risk of yellow fever infection. The vaccine should be administered at least 10 days before travelling to an area where the disease is endemic. One dose provides immunity for life.

The vaccine is designed to prevent typhoid fever in adults, adolescents and children travelling to areas where the disease is endemic. One dose of the vaccine is sufficient to provide immunity.